[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"brand-zailab":3},{"head":4,"company":37,"invest":42,"children":43,"shops":44,"category":45,"sameIndustry":5,"rid":6},{"createTime":5,"updateTime":5,"createBy":5,"updateBy":5,"brandId":6,"brandLogo":7,"brandImage":5,"brandName":8,"webName":9,"balias":5,"enterId":10,"mainindustry":11,"industry":5,"brandType":5,"brandHonor":5,"brandTel":12,"establishdate":13,"brandBirth":14,"cityarea":5,"brandWebsite":5,"brandSobp":5,"brandVisit":5,"totalVisits":15,"status":16,"isDeleted":16,"comment":5,"remark":5,"logoExistStatus":17,"imageExistStatus":17,"industryId":5,"industryRanking":5,"score":5,"enterName":18,"mallShopList":19,"brandSummary":5,"likes":5,"unlikes":5,"follow":5,"pagetitle":20,"pagekeywords":21,"pagedesc":22,"brandContent":23,"province":5,"city":5,"area":5,"detailaddress":24,"unifiedscc":25,"enterType":26,"enterLegalperson":27,"enterStablishdate":28,"regauthority":29,"licenseValidity":30,"approvaldate":31,"regcapital":32,"incapital":32,"businessscope":33,"ownBrand":5,"enterTelphone":12,"enterWebsite":34,"business":35,"enterQq":5,"enterMail":36,"bindUser":5,"enterMployeenum":5,"regcapitalunit":5,"abnormal":5,"yeartax":5,"regtrademark":5},null,"76788","\u002Fprofile\u002Fupload\u002F2023\u002F12\u002F02\u002Febad03168337f3f99bac991fc5c5535f.gif","再鼎医药ZaiLab","zailab",68917,10006,"021-61632588","2014年","上海市",543,0,"1","再鼎医药（上海）有限公司",[],"再鼎医药ZaiLab简介-再鼎医药用品-品牌之家","再鼎医药ZaiLab品牌介绍,再鼎医药用品好不好,再鼎怎么样,再鼎,再鼎医药(上海)有限公司","再鼎医药ZaiLab品牌简介，品牌之家为你介绍再鼎医药(上海)有限公司旗下再鼎医药ZaiLab品牌信息，包括品牌介绍、联系方式、主营产品、最新评论、点赞数量等，告诉你再鼎医药用品怎么样，致力于帮助你了解再鼎医药ZaiLab真实有效的品牌相关信息。","再鼎医药是一家立足中国、全球运营的创新型生物制药公司，致力于为中国及全球的患者提供癌症、自身免疫、感染性疾病和中枢神经系统领域的创新药物。\n\n再鼎医药总部位于上海，自2014年成立以来，已与多个全球领先的生物制药公司建立了合作伙伴关系，打造起广泛的后期创新候选药物产品线。对于寻求进入中国市场以及寻找国际临床开发长期战略合作伙伴的全球生物制药公司来说，再鼎医药凭借一系列成功合作案例，成为了业界值得信赖的合作伙伴人选。通过这些成功合作，再鼎医药打造起中国创新生物技术公司中强大的晚期肿瘤产品管线。同时我们正在不断提高内部研发能力，以进一步补充我们的产品线，目标是未来每年可以有1-2个全球新药临床试验申请（IND）。\n\n再鼎医药正在快速发展成为一家全面整合的生物制药公司，在中国和全球各地发现、开发、生产并商业化创新药物。为此，我们在中国成立了内部研发中心以推动药物研发，打造了一支强大的临床开发和运营团队，并建立了自有的生产基地。此外，我们还成立了一支专业化的商业团队，以支持创新产品在中国的推广。我们相信，这种整合策略将为再鼎医药带来可持续的竞争优势。\n\n再鼎医药于2017年9月在美国纳斯达克上市，于2020年9月在香港联交所二次上市。随着公司的快速发展，再鼎医药已在中国、美国多地设立分公司或办事处，并于2018年12月在美国旧金山成立美国总部。截至2021年9月，公司在全球拥有超过1800名员工。","中国（上海）自由贸易试验区金科路4560号1号楼南楼4层","9131000008621843XU","有限责任公司(港澳台法人独资)","YING DU","2014-01-06","自由贸易试验区市场监管局","2014-01-06 至 2044-01-05","2023-10-25","46,650万(美元)","许可项目：药品生产；第三类医疗器械经营；药品批发；药品进出口。（依法须经批准的项目，经相关部门批准后方可开展经营活动，具体经营项目以相关部门批准文件或许可证件为准）\n一般项目：医学研究和试验发展（除人体干细胞、基因诊断与治疗技术开发和应用）；技术服务、技术开发、技术咨询、技术交流、技术转让、技术推广；生物化工产品技术研发；生物基材料聚合技术研发；生物基材料制造；生物基材料销售；第一类医疗器械生产；第一类医疗器械销售；第二类医疗器械销售；进出口代理；货物进出口；技术进出口。（除依法须经批准的项目外，凭营业执照依法自主开展经营活动）","www.zailaboratory.com","研究和试验发展","info@zailaboratory.com",{"enterId":38,"enterName":18,"province":5,"city":5,"area":5,"detailaddress":24,"unifiedscc":25,"enterType":26,"enterLegalperson":27,"enterStablishdate":28,"regauthority":29,"licenseValidity":30,"approvaldate":31,"regcapital":32,"incapital":32,"businessscope":33,"ownBrand":5,"enterTelphone":12,"enterWebsite":34,"business":35,"performance":39,"socialSecurity":40,"registrationNumber":41,"enterQq":5,"enterMail":36,"bindUser":5,"enterMployeenum":5,"regcapitalunit":5,"abnormal":5,"yeartax":5,"status":16,"regtrademark":5,"remark":5},"68917","开业","601人","310115400291117",{"createTime":5,"updateTime":5,"createBy":5,"updateBy":5,"id":5,"brandId":5,"brandName":5,"busmodel":5,"franchiseFund":5,"totalStores":5,"devmodel":5,"franchiseIndustry":5,"investmenttel":5,"suitablePeople":5,"state":5},[],[],[46,65],{"createTime":47,"updateTime":48,"createBy":5,"updateBy":5,"industryId":49,"webId":5,"industryName":50,"industryAlias":51,"industryIcon":5,"industryTrans":52,"pageTitle":53,"pageDesc":54,"pageKeywords":55,"mainTitle":56,"pageSubtitle":57,"indSummary":58,"industryLevel":59,"parentId":60,"parentName":61,"sortOrder":62,"status":16,"classifyVisit":63,"totalVisits":64,"searchName":5,"starLevel":5,"limit":5},"2000-01-01 00:00:00","2026-06-14 16:50:00","5593","药品","药品,药物,医药制剂,医疗药品,医用药品,药片","\u002Fprofile\u002Fupload\u002F2023\u002F11\u002F08\u002F175454c1767ce2414a13f8c3c16194de.png","十大药品品牌-药品十大厂家-ZGALL品牌榜","2026年药品行业十大品牌权威发布！药品排行榜前十名品牌有三九、同仁堂、广药白云山、云南白药、太极药业、修正、念慈菴、天士力、扬子江药业、仁和。药品10大品牌由品牌中国重磅推出，旨在呈现行业领域标杆品牌，展现行业优秀企业实力，帮助你了解药品哪个牌子好。","药品十大品牌排名,OTC药品十大品牌,非处方药品牌十大排行榜,OTC药品排行,药品品牌有哪些","药品品牌排行榜","2026药品品牌排行榜，OTC药品排行，OTC常用药品有哪些","药品什么牌子好？品牌TOP榜权威发布2026年药品十大品牌名录；居前十的有：三九999、同仁堂、广药白云山、云南白药、太极药业TAIJI、修正、京都念慈菴、天士力TASLY、扬子江药业、仁和药业RenHe等，【行业品牌名录】基于大数据与人工智能技术，整合300+国际权威榜单及企业申报数据，通过算法分析市场占有率、创新力等12项指标，并解析超百万条舆情信息，采用加权模型（算法60%+专家30%+用户10%）生成动态排名。数据月度更新，申报需通过ISO认证审核，排名不分先后，仅供参考。",3,1411,"医药用品",20,2,1047,{"createTime":47,"updateTime":66,"createBy":5,"updateBy":5,"industryId":67,"webId":5,"industryName":68,"industryAlias":5,"industryIcon":5,"industryTrans":69,"pageTitle":70,"pageDesc":71,"pageKeywords":72,"mainTitle":73,"pageSubtitle":74,"indSummary":75,"industryLevel":59,"parentId":60,"parentName":5,"sortOrder":76,"status":16,"classifyVisit":5,"totalVisits":77,"searchName":5,"starLevel":5,"limit":5},"2026-06-16 16:50:00","10006","生物科技","\u002Fprofile\u002Fupload\u002F2023\u002F11\u002F08\u002F19f46e89d8cd077b73c7adb33bb2b59f.png","生物科技公司十大排行榜-国内知名生物科技公司有哪些-ZGALL品牌榜","2026年十大生物科技公司排行榜最新发布，生物科技公司十大排行榜前十名有中国生物、中国生物制药、百济神州、恒瑞、豪森药业、百利天恒、康方、复星医药、石药、信达。生物科技十大品牌排行榜由品牌研究部门收集整理大数据分析研究得出，帮助你了解中国生物科技公司有哪些。","生物科技公司排名前十有哪些,中国生物科技公司排名前十,生物科技有限公司排名,中国生物科技公司排名,全国生物科技公司排名","生物科技品牌排行榜","2026生物科技公司，生物制药公司排行榜，国内生物医药科技公司有哪些","生物科技哪个好？品牌TOP榜权威发布2026年生物科技名录；居前十的有：中国生物CNBG、中国生物制药、百济神州BeiGene、恒瑞医药、豪森药业、百利天恒、康方Akesobio、复星医药、石药CSPC、信达生物Innovent等，【行业品牌名录】基于大数据与人工智能技术，整合300+国际权威榜单及企业申报数据，通过算法分析市场占有率、创新力等12项指标，并解析超百万条舆情信息，采用加权模型（算法60%+专家30%+用户10%）生成动态排名。数据月度更新，申报需通过ISO认证审核，排名不分先后，仅供参考。",99,589]